Shenyang Pharmaceutical University

Chinese Academy of Sciences

General Hospital of Pla Northern Theater Command

General Hospital of Chinese Pla Northern Theater Command

Dan Liu

Yaling Han

Yongkui Jing

Yang Li

Linxiang Zhao

Jingyang Sun

Ming Liang

Rui Wang

Xiaozeng Wang

Hao Liu

Jin Zhang

Qingwen Li

Hehua Jin

Song Qiu

Fei Li

Xuan Zhao

Xiaolin Zhang

Haixu Song

Jingli Wang

Meili Liu

Zhenjun Bian

Jinling Lv

Chenghui Yan

Hongbo Li

Peng Lin

Xiaoxiang Tian

Hang Zhong

An ambulance-type mobile catheter room for cardiovascular interventional surgery enables interventional diagnosis and treatment devices for acute and severe cardiovascular diseases to be deployed quickly, is flexible and high in adaptability, and provides hardware devices for cardiovascular diagnosis and treatment interventional surgeons to timely diagnose and treat patients. The ambulance-type mobile catheter room for cardiovascular interventional surgery includes an ambulance. The ambulance is internally provided with an antibacterial internal environment, a robotic angiography machine system, a wireless medical Internet of Things system, a self-generating system and an auxiliary system.

Ambulance-type mobile catheter room for cardiovascular interventional surgery

A vehicle-mounted angiography machine with a double-robotic-arm type structure is used for interventional surgery diagnosis and treatment on patients on the site of cardiovascular diseases and on the way and occupies a small space. The vehicle-mounted angiography machine includes a six-degree-of-freedom robotic lower arm at the lower portion of an ambulance body space, a three-degree-of-freedom mobile table located in the middle of the space for moving a patient, and a seven-degree-of-freedom robotic upper arm at the upper portion of the space. An end portion of the upper arm is connected to a flat panel detector of the angiography machine, and an end portion of the lower arm is connected to an anode ball tube of the angiography machine, Large-scale isocentric detection is realized by cooperation of the central motion of the upper arm and the lower arm and the up-down, left-right and front-back motion of the table.

Vehicle-mounted angiography machine with double-robotic-arm type structure

The present invention relates to a medical use of Cellular Repressor of E1A-stimulated Genes (CREG), in particular to a use of CREG protein or active fragment thereof in manufacture of a medicament for preventing and/or treating myocardial infarction, a use in manufacture of a medicament for preventing and/or treating ventricular remodeling after myocardial infarction and heart failure after myocardial infarction, a use in manufacture of a medicament for prevention and/or treatment of myocardial ischemia-reperfusion injury, a use in manufacture of a medicament for prevention and/or treatment of salt-sensitive hypertensive myocardial fibrosis.

Medical use of CREG protein

The disclosure discloses a method and reagent for improving a yield of selective dispersion of semiconducting carbon nanotubes. The method comprises: fully mixing single walled carbon nanotube samples, a first polymer, and a second polymer in a solvent to form a liquid phase mixed system, enabling the single walled carbon nanotube samples to be fully dispersed in the liquid phase mixed system, centrifuging the liquid phase mixed system, and separating a supernatant to implement selective separation of the semiconducting single walled carbon nanotubes; wherein both the first polymer and the second polymer can specifically bind to the semiconducting single walled carbon nanotubes; a speed of binding the first polymer to the semiconducting single walled carbon nanotubes is greater than a speed of binding the second polymer to the semiconducting single walled carbon nanotubes; and a binding strength between the first polymer and the semiconducting single walled carbon nanotubes is less than a binding strength between the second polymer and the semiconducting single walled carbon nanotubes. The disclosure can realize high-yielding selective separation of high-purity and highly dispersive semiconductoring single walled carbon nanotubes, thereby reducing costs, and improving the repeatability and stability of the separation.

Method and reagent for improving yield of selective dispersion of semiconducting carbon nanotubes

The present invention belongs to the field of medicinal technique, specifically relates to nitrogen-containing heterocyclic ring-substituted dihydroartemisinin derivatives and their optical isomers according to formula I or II; wherein substituent X, Y, R, R, R, Rand Rare as defined in the Description. The derivatives and compositions thereof can be prepared into clinically acceptable tablets, capsules, injections, ointments, etc., and thus have pharmaceutical uses in the treatment and/or prevention of cancers. 

Nitrogen-containing heterocyclic ring substituted dihydroartemisinin derivatives and use thereof

The invention relates to 2-methylene-5-substituted-methylenecyclopentanone derivatives of formula I, and the use thereof. The derivatives of formula I as active components are useful for preparing a medicine for the treatment and/or prevention of cancer diseases such as breast cancer, lung cancer, colon cancer, rectal cancer, stomach cancer, prostate cancer, bladder cancer, uterus cancer, pancreatic cancer and ovary cancer. The active compounds of the invention may be used as an anticancer drug alone or used in combination with one or more other antitumor drugs. A combined therapy can be carried out by administrating each therapeutic component concurrently, subsequently or separately. 

2-methylene-5-substituted-methylenecyclopentanone derivatives and use thereof

The invention belongs to pharmaceutical field. The invention relates to the compounds according to Formula I, including their optically active forms, pharmaceutically acceptable salts or hydrates, and the pharmaceutical composition comprising thereof as active ingredient; uses in the preparation of vascular endothelial growth factor receptor tyrosine kinase inhibitors, and uses in the preparation of medicament for the treatment and/or prevention of cancer. 

Aromatic ring fused triazine derivatives and uses thereof

Growing community of inventors

Shenyang, China

Dan Liu